Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: Oncologic safety and reproductive outcomes

Gynecologic Oncology

Volumn 110, Issue 3, 2008, Pages 345-353

  Park, Jeong Yeol ^a   Kim, Dae Yeon ^a   Suh, Dae Shik ^a   Kim, Jong Hyeok ^a   Kim, Yong Man ^a   Kim, Young Tak ^a   Nam, Joo Hyun ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Epithelial ovarian cancer; Fertility sparing surgery; Oncologic safety; Reproductive outcome

Indexed keywords

PACLITAXEL;

ADOLESCENT; ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; EPITHELIAL OVARIAN CANCER; FEMALE; FEMALE GENITAL SYSTEM; FERTILITY SPARING SURGERY; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONCOLOGY; OVARY CANCER; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROGENY; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADENOCARCINOMA, CLEAR CELL; ADENOCARCINOMA, MUCINOUS; ADULT; CARCINOMA, ENDOMETRIOID; DISEASE-FREE SURVIVAL; FEMALE; FERTILITY; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OVARIAN NEOPLASMS; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 50149084447     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.04.040     Document Type: Article

References (48)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
2. McGuire W.P., Hoskins W.J., Brady M.F., Kucera P.R., Partridge E.E., Look K.Y., et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 334 (1996) 1-6
3. FIGO_cancer_committee. Staging announcement. Gynecol Oncol 50 (1986) 383-385
4. Low J.J., Perrin L.C., Crandon A.J., and Hacker N.F. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases. Cancer 89 (2000) 391-398
5. Brewer M., Gershenson D.M., Herzog C.E., Mitchell M.F., Silva E.G., and Wharton J.T. Outcome and reproductive function after chemotherapy for ovarian dysgerminoma. J Clin Oncol 17 (1999) 2670-2675
6. Morice P., Camatte S., El Hassan J., Pautier P., Duvillard P., and Castaigne D. Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors. Fertil Steril 75 (2001) 92-96
7. Green J.A. Early ovarian cancer-time for a rethink on stage?. Gynecol Oncol 90 (2003) 235-237
8. Duska L.R., Chang Y.C., Flynn C.E., Chen A.H., Goodman A., Fuller A.F., et al. Epithelial ovarian carcinoma in the reproductive age group. Cancer 85 (1999) 2623-2629
9. Plaxe S.C., Braly P.S., Freddo J.L., McClay E., Kirmani S., and Howell S.B. Profiles of women age 30-39 and age less than 30 with epithelial ovarian cancer. Obstet Gynecol 81 (1993) 651-654
10. DiSaia P.J. Fertility-sparing treatment of patients with ovarian cancer. Compr Ther 16 (1990) 35-42
11. Voest E.E., van Houwelingen J.C., and Neijt J.P. A meta-analysis of prognostic factors in advanced ovarian cancer with median survival and overall survival (measured with the log (relative risk] as main objectives. Eur J Cancer Clin Oncol 25 (1989) 711-720
12. Heintz A.P., Odicino F., Maisonneuve P., Beller U., Benedet J.L., Creasman W.T., et al. Carcinoma of the ovary. Int J Gynaecol Obstet 83 Suppl 1 (2003) 135-166
13. Colombo N., Chiari S., Maggioni A., Bocciolone L., Torri V., and Mangioni C. Controversial issues in the management of early epithelial ovarian cancer: conservative surgery and role of adjuvant therapy. Gynecol Oncol 55 (1994) S47-S51
14. Brown C., Hyman J., Almadrones L., Curtin J., and Hoskins W. Conservative surgical management of early epithelial ovarian cancer (EOC). Proc ASCO 14 (1995) 766
15. Zanetta G., Chiari S., Rota S., Bratina G., Maneo A., Torri V., et al. Conservative surgery for stage I ovarian carcinoma in women of childbearing age. Br J Obstet Gynaecol 104 (1997) 1030-1035
16. Raspagliesi F., Fontanelli R., Paladini D., and di Re E.M. Conservative surgery in high-risk epithelial ovarian carcinoma. J Am Coll Surg 185 (1997) 457-460
17. Morice P., Wicart-Poque F., Rey A., El-Hassan J., Pautier P., Lhomme C., et al. Results of conservative treatment in epithelial ovarian carcinoma. Cancer 92 (2001) 2412-2418
18. Schilder J.M., Thompson A.M., DePriest P.D., Ueland F.R., Cibull M.L., Kryscio R.J., et al. Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy. Gynecol Oncol 87 (2002) 1-7
19. Morice P., Leblanc E., Rey A., Baron M., Querleu D., Blanchot J., et al. Conservative treatment in epithelial ovarian cancer: results of a multicentre study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) and SFOG (Societe Francaise d'Oncologie Gynecologique). Hum Reprod 20 (2005) 1379-1385
20. Borgfeldt C., Iosif C., and Masback A. Fertility-sparing surgery and outcome in fertile women with ovarian borderline tumors and epithelial invasive ovarian cancer. Eur J Obstet Gynecol Reprod Biol 134 (2007) 110-114
21. DiSaia P.J. Conservative management of the patient with early gynecologic cancer. CA Cancer J Clin 39 (1989) 135-154
22. Young R.C., Decker D.G., Wharton J.T., Piver M.S., Sindelar W.F., Edwards B.K., et al. Staging laparotomy in early ovarian cancer. Jama 250 (1983) 3072-3076
23. Ayhan A., Gultekin M., Celik N.Y., Dursun P., Taskiran C., Aksan G., et al. Occult metastasis in early ovarian cancers: risk factors and associated prognosis. Am J Obstet Gynecol 196 81 (2007) e1-6
24. Zanetta G., Rota S., Chiari S., Bonazzi C., Bratina G., Torri V., et al. The accuracy of staging: an important prognostic determinator in stage I ovarian carcinoma. A multivariate analysis. Ann Oncol 9 (1998) 1097-1101
25. Stier E.A., Barakat R.R., Curtin J.P., Brown C.L., Jones W.B., and Hoskins W.J. Laparotomy to complete staging of presumed early ovarian cancer. Obstet Gynecol 87 (1996) 737-740
26. Panici P.B., Maggioni A., Hacker N., Landoni F., Ackermann S., Campagnutta E., et al. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst 97 (2005) 560-566
27. Meier W.J. Lympnadenectomy in stage I ovarian cancer. Proc ASCO 19 (2000) 1541 2000
28. Benedetti-Panici P., Greggi S., Maneschi F., Scambia G., Amoroso M., Rabitti C., et al. Anatomical and pathological study of retroperitoneal nodes in epithelial ovarian cancer. Gynecol Oncol 51 (1993) 150-154
29. Petru E., Lahousen M., Tamussino K., Pickel H., Stranzl H., Stettner H., et al. Lymphadenectomy in stage I ovarian cancer. Am J Obstet Gynecol 170 (1994) 656-662
30. Baiocchi G., Raspagliesi F., Grosso G., Fontanelli R., Cobellis L., and Di Re E. Early ovarian cancer: is there a role for systematic pelvic and para-aortic lymphadenectomy?. Int J Gynecol Cancer 8 (1998) 103-108
31. Ramirez P.T., Slomovitz B.M., McQuinn L., Levenback C., and Coleman R.L. Role of appendectomy at the time of primary surgery in patients with early-stage ovarian cancer. Gynecol Oncol 103 (2006) 888-890
32. Ayhan A., Gultekin M., Taskiran C., Salman M.C., Celik N.Y., Yuce K., et al. Routine appendectomy in epithelial ovarian carcinoma: is it necessary?. Obstet Gynecol 105 (2005) 719-724
33. Weinstein D., and Polishuk W.Z. The role of wedge resection of the ovary as a cause for mechanical sterility. Surg Gynecol Obstet 141 (1975) 417-418
34. Munnell E.W. Is conservative therapy ever justified in stage I (IA) cancer of the ovary?. Am J Obstet Gynecol 103 (1969) 641-653
35. Benjamin I., Morgan M.A., and Rubin S.C. Occult bilateral involvement in stage I epithelial ovarian cancer. Gynecol Oncol 72 (1999) 288-291
36. Kottmeier H.L. 1968. Surgical management-conservative surgery. In: Gentil F., and Junqueria A.C. (Eds). Ovarian cancer 2 (1968), Springer Verlag, New York
37. Villa A., Parazzini F., Acerboni S., Guarnerio P., and Bolis G. Survival and prognostic factors of early ovarian cancer. Br J Cancer 77 (1998) 123-124
38. Young R.C., Walton L.A., Ellenberg S.S., Homesley H.D., Wilbanks G.D., Decker D.G., et al. Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials. N Engl J Med 322 (1990) 1021-1027
39. Seidman J.D., Horkayne-Szakaly I., Haiba M., Boice C.R., Kurman R.J., and Ronnett B.M. The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin. Int J Gynecol Pathol 23 (2004) 41-44
40. Annual report of gynecologic cancer registry program in Korean for 2002. Korean J Obstet Gynecol 47 6 (2004) 1029-1070
41. Cho Y.H., Kim D.Y., Kim J.H., Kim Y.M., Kim K.R., Kim Y.T., et al. Is complete surgical staging necessary in patients with stage I mucinous epithelial ovarian tumors?. Gynecol Oncol 103 (2006) 878-882
42. Ozols R.F., Rubin S.C., Thomas G.M., and Robboy S.J. Epithelial Ovarian Cancer. In: Hoskins W.J., Perez C.A., Young R.C., Barakat R., Markman M., and Randall M. (Eds). Principles and practice of gynecologic oncology. 4th (2005), Lippincott Williams & Wilkins, Philadelphia 895-987
43. Moore M.M., Tewari K., Rose G.S., Fruehauf J.P., and DiSaia P.J. Long-term consequences following conservative management of epithelial ovarian cancer in an infertile patient. Gynecol Oncol 73 (1999) 452-454
44. Garber J.E., and Offit K. Hereditary cancer predisposition syndromes. J Clin Oncol 23 (2005) 276-292
45. Lancaster J.M., Bethan Powell C., Kauff N.D., Cass I., Chen L.M., Lu K.H., et al. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions. Gynecol Oncol 107 (2007) 159-162
46. Gershenson D.M. Menstrual and reproductive function after treatment with combination chemotherapy for malignant ovarian germ cell tumors. J Clin Oncol 6 (1988) 270-275
47. Kanazawa K., Suzuki T., and Sakumoto K. Treatment of malignant ovarian germ cell tumors with preservation of fertility: reproductive performance after persistent remission. Am J Clin Oncol 23 (2000) 244-248
48. Averette H.E., Boike G.M., and Jarrell M.A. Effects of cancer chemotherapy on gonadal function and reproductive capacity. CA Cancer J Clin 40 (1990) 199-209